-+ 0.00%
-+ 0.00%
-+ 0.00%
Placo announced that the “porcine circovirus type 2 baculovirus vector and mycoplasma pneumoniae double inactivated vaccine”, which was jointly declared by the company's wholly-owned subsidiary, and that the Ministry of Agriculture and Rural Affairs approved the “New Veterinary Drug Registration Certificate” issue. The vaccine is used to prevent diseases caused by porcine circovirus type 2 infection and mycoplasma porcine pneumonia. The immunization period is 4 months. Before the product is marketed, it is also necessary to obtain a veterinary drug product approval number. Obtaining a certificate will enrich the company's range of swine vaccines and enhance product competitiveness.
Share
Listen to the news
Placo announced that the “porcine circovirus type 2 baculovirus vector and mycoplasma pneumoniae double inactivated vaccine”, which was jointly declared by the company's wholly-owned subsidiary, and that the Ministry of Agriculture and Rural Affairs approved the “New Veterinary Drug Registration Certificate” issue. The vaccine is used to prevent diseases caused by porcine circovirus type 2 infection and mycoplasma porcine pneumonia. The immunization period is 4 months. Before the product is marketed, it is also necessary to obtain a veterinary drug product approval number. Obtaining a certificate will enrich the company's range of swine vaccines and enhance product competitiveness.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending